SIC 8071 – Medical Laboratories
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 5.45 |
Book Value / Share | 0.89 |
Price / Book | n/a |
NCAV ($M) | 1.66 |
NCAV / Share | 0.27 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.43 |
Return on Assets (ROA) | -0.24 |
Return on Equity (ROE) | -0.45 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.59 |
Current Ratio | 1.59 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.05 |
Assets | 9.84 |
Liabilities | 4.39 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Similar Companies | |
---|---|
MEDD – Medical Imaging Corp. | OPGN – OpGen, Inc. |
PCHM – PharmChem, Inc. | RTNXF – Renalytix Plc |
Financial data and stock pages provided by
Fintel.io